# S. Mazzuoli

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/s-mazzuoli/

## Facts

| Field | Value |
| --- | --- |
| Citations | 896 |
| Field | Inflammatory Bowel Disease |
| h-index | 16 |
| i10-index | 20 |
| Last Known Institution | Ospedale dei Pellegrini |
| OpenAlex ID | https://openalex.org/A5091796374 |
| Works | 94 |

## Researcher papers

Showing 12 of 13.

- [Definition and evaluation of mucosal healing in clinical practice](https://scholariq.org/papers/definition-and-evaluation-of-mucosal-healing-in-clinical-practice/)
- [Total parenteral nutrition-related gastroenterological complications](https://scholariq.org/papers/total-parenteral-nutrition-related-gastroenterological-complications/)
- [Cholestasis Induced by Total Parenteral Nutrition](https://scholariq.org/papers/cholestasis-induced-by-total-parenteral-nutrition/)
- [Prevalence of home artificial nutrition in Italy in 2005: A survey by the Italian Society for Parenteral and Enteral Nutrition (SINPE)](https://scholariq.org/papers/prevalence-of-home-artificial-nutrition-in-italy-in-2005-a-survey-by-the-italian/)
- [The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy](https://scholariq.org/papers/the-prosit-cohort-of-infliximab-biosimilar-in-ibd-a-prolonged-follow-up-on-the/)
- [Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study](https://scholariq.org/papers/long-term-outcomes-of-acute-severe-ulcerative-colitis-in-the-rescue-therapy-era/)
- [An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors](https://scholariq.org/papers/an-objective-comparison-of-vedolizumab-and-ustekinumab-effectiveness-in-crohn-s/)
- [Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)](https://scholariq.org/papers/use-of-biosimilars-in-inflammatory-bowel-disease-a-position-update-of-the/)
- [Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study](https://scholariq.org/papers/real-life-effectiveness-of-ustekinumab-in-inflammatory-bowel-disease-patients/)
- [A simplified clinical risk score predicts the need for early endoscopy in non-variceal upper gastrointestinal bleeding](https://scholariq.org/papers/a-simplified-clinical-risk-score-predicts-the-need-for-early-endoscopy-in-non/)
- [Forty-eight months outcomes of teduglutide treatment in adult stable patients with short bowel syndrome and home parenteral nutrition dependence: A real-world Italian single-center observational cohort study](https://scholariq.org/papers/forty-eight-months-outcomes-of-teduglutide-treatment-in-adult-stable-patients/)
- [Intestinal iatrogenic hyperadaptation in patients with short bowel syndrome and Crohn's disease: Is this an indication for mandatory lifelong injections of teduglutide?](https://scholariq.org/papers/intestinal-iatrogenic-hyperadaptation-in-patients-with-short-bowel-syndrome-and/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Clinical Nutrition and Gastroenterology](https://scholariq.org/topics/clinical-nutrition-and-gastroenterology/)
- [Nutrition and Health in Aging](https://scholariq.org/topics/nutrition-and-health-in-aging/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Researcher university

- [Ospedale dei Pellegrini](https://scholariq.org/institutions/ospedale-dei-pellegrini/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
